Results 61 to 70 of about 95,094 (198)
Artificial exosomes for translational nanomedicine
Journal of Nanobiotechnology, 2021 Exosomes are lipid bilayer membrane vesicles and are emerging as competent nanocarriers for drug delivery. The clinical translation of exosomes faces many challenges such as massive production, standard isolation, drug loading, stability and quality ...
Yongjiang Li +7 more
semanticscholar +1 more source
Extracellular Vesicles as Drug Delivery Systems in Cancer
Pharmaceutics, 2020 Within tumors, Cancer Stem Cell (CSC) subpopulation has an important role in maintaining growth and dissemination while preserving high resistance against current treatments.
Laia Hernandez-Oller +6 more
doaj +1 more source
Application Perspectives of Nanomedicine in Cancer Treatment
Frontiers in Pharmacology, 2022 Cancer is a disease that seriously threatens human health. Based on the improvement of traditional treatment methods and the development of new treatment modes, the pattern of cancer treatment is constantly being optimized.
Shanshan Hou +6 more
doaj +1 more source
Journal of nanomaterials, 2019 The study of nanostructured drug delivery systems allows the development of novel platforms for the efficient transport and controlled release of drug molecules in the harsh microenvironment of diseased tissues of living systems, thus offering a wide ...
D. Lombardo, M. Kiselev, M. T. Caccamo
semanticscholar +1 more source
Advanced strategies to thwart foreign body response to implantable devices
Bioengineering & Translational Medicine, 2022 Mitigating the foreign body response (FBR) to implantable medical devices (IMDs) is critical for successful long‐term clinical deployment. The FBR is an inevitable immunological reaction to IMDs, resulting in inflammation and subsequent fibrotic ...
Simone Capuani +3 more
doaj +1 more source
Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
BMC Pharmacology and Toxicology, 2022 Background Allopurinol (ALP), a xanthine oxidase inhibitor, is a first line drug for the treatment of gout and hyperuricemia. Being the member of BCS class II drugs, ALP has solubility problem, which affects its bioavailability.
Zakir Ali +8 more
doaj +1 more source
Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
Frontiers in Pharmacology, 2017 Nanomedicines including liposomes, micelles, and nanoparticles based on the enhanced permeability and retention (EPR) effect have become the mainstream for tumor treatment owing to their superiority over conventional anticancer agents. Advanced design of
Bo Zhang, Bo Zhang, Yu Hu, Zhiqing Pang
doaj +1 more source
Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine
Bioactive Materials, 2021 Nanomedicine involves the use of engineered nanoscale materials in an extensive range of diagnostic and therapeutic applications and can be applied to the treatment of many diseases.
Xi Chen +3 more
doaj
Nanomedicine for drug delivery in South Africa: a protocol for systematic review
Systematic Reviews, 2018 Background The emergence of nanomedicine in the past decade has changed the landscape of disease diagnosis and treatment. Nanomedicine makes use of nanostructures for applications in different fields of medicine, including drug delivery, biosensors ...
Trust Saidi +2 more
doaj +1 more source
Silver Nanoparticles: Synthesis and Application for Nanomedicine
International Journal of Molecular Sciences, 2019 Over the past few decades, metal nanoparticles less than 100 nm in diameter have made a substantial impact across diverse biomedical applications, such as diagnostic and medical devices, for personalized healthcare practice.
Sang Hun Lee, Bong-Hyun Jun
semanticscholar +1 more source